| GO:0007202 | activation of phospholipase C activity | 100.0% (2/2) | 12.25 | 0.0 | 1e-06 |
| GO:0010863 | positive regulation of phospholipase C activity | 100.0% (2/2) | 12.25 | 0.0 | 1e-06 |
| GO:0010944 | negative regulation of transcription by competitive promoter binding | 100.0% (2/2) | 12.25 | 0.0 | 1e-06 |
| GO:0030421 | defecation | 100.0% (2/2) | 12.25 | 0.0 | 1e-06 |
| GO:0060749 | mammary gland alveolus development | 100.0% (2/2) | 12.25 | 0.0 | 1e-06 |
| GO:0098891 | extrinsic component of presynaptic active zone membrane | 100.0% (2/2) | 12.25 | 0.0 | 1e-06 |
| GO:0140374 | antiviral innate immune response | 100.0% (2/2) | 12.25 | 0.0 | 1e-06 |
| GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 100.0% (2/2) | 12.25 | 0.0 | 1e-06 |
| GO:0010518 | positive regulation of phospholipase activity | 100.0% (2/2) | 11.8 | 0.0 | 1e-06 |
| GO:0030061 | mitochondrial crista | 100.0% (2/2) | 11.8 | 0.0 | 1e-06 |
| GO:0039519 | modulation by virus of host autophagy | 100.0% (2/2) | 11.8 | 0.0 | 1e-06 |
| GO:0044830 | modulation by host of viral RNA genome replication | 100.0% (2/2) | 11.8 | 0.0 | 1e-06 |
| GO:0052040 | modulation by symbiont of host programmed cell death | 100.0% (2/2) | 11.8 | 0.0 | 1e-06 |
| GO:0060193 | positive regulation of lipase activity | 100.0% (2/2) | 11.8 | 0.0 | 1e-06 |
| GO:0075044 | positive regulation by symbiont of host autophagy | 100.0% (2/2) | 11.8 | 0.0 | 1e-06 |
| GO:0075071 | modulation by symbiont of host autophagy | 100.0% (2/2) | 11.8 | 0.0 | 1e-06 |
| GO:1904092 | regulation of autophagic cell death | 100.0% (2/2) | 11.8 | 0.0 | 1e-06 |
| GO:2000322 | regulation of glucocorticoid receptor signaling pathway | 100.0% (2/2) | 11.8 | 0.0 | 1e-06 |
| GO:0001552 | ovarian follicle atresia | 100.0% (2/2) | 12.45 | 0.0 | 1e-06 |
| GO:0001846 | opsonin binding | 100.0% (2/2) | 12.45 | 0.0 | 1e-06 |
| GO:0001848 | complement binding | 100.0% (2/2) | 12.45 | 0.0 | 1e-06 |
| GO:0001850 | complement component C3a binding | 100.0% (2/2) | 12.45 | 0.0 | 1e-06 |
| GO:0001851 | complement component C3b binding | 100.0% (2/2) | 12.45 | 0.0 | 1e-06 |
| GO:0023035 | CD40 signaling pathway | 100.0% (2/2) | 12.45 | 0.0 | 1e-06 |
| GO:0030449 | regulation of complement activation | 100.0% (2/2) | 12.45 | 0.0 | 1e-06 |
| GO:0031871 | proteinase activated receptor binding | 100.0% (2/2) | 12.45 | 0.0 | 1e-06 |
| GO:0032740 | positive regulation of interleukin-17 production | 100.0% (2/2) | 12.45 | 0.0 | 1e-06 |
| GO:0035632 | mitochondrial prohibitin complex | 100.0% (2/2) | 12.45 | 0.0 | 1e-06 |
| GO:0045917 | positive regulation of complement activation | 100.0% (2/2) | 12.45 | 0.0 | 1e-06 |
| GO:0050847 | progesterone receptor signaling pathway | 100.0% (2/2) | 12.45 | 0.0 | 1e-06 |
| GO:0072538 | T-helper 17 type immune response | 100.0% (2/2) | 12.45 | 0.0 | 1e-06 |
| GO:1990051 | activation of protein kinase C activity | 100.0% (2/2) | 12.45 | 0.0 | 1e-06 |
| GO:0000423 | mitophagy | 100.0% (2/2) | 12.08 | 0.0 | 1e-06 |
| GO:0045745 | positive regulation of G protein-coupled receptor signaling pathway | 100.0% (2/2) | 12.08 | 0.0 | 1e-06 |
| GO:1900274 | regulation of phospholipase C activity | 100.0% (2/2) | 12.08 | 0.0 | 1e-06 |
| GO:1905330 | regulation of morphogenesis of an epithelium | 100.0% (2/2) | 12.08 | 0.0 | 1e-06 |
| GO:0002753 | cytoplasmic pattern recognition receptor signaling pathway | 100.0% (2/2) | 11.93 | 0.0 | 1e-06 |
| GO:0035902 | response to immobilization stress | 100.0% (2/2) | 11.93 | 0.0 | 1e-06 |
| GO:0039520 | induction by virus of host autophagy | 100.0% (2/2) | 11.93 | 0.0 | 1e-06 |
| GO:0039528 | cytoplasmic pattern recognition receptor signaling pathway in response to virus | 100.0% (2/2) | 11.93 | 0.0 | 1e-06 |
| GO:0039529 | RIG-I signaling pathway | 100.0% (2/2) | 11.93 | 0.0 | 1e-06 |
| GO:0060444 | branching involved in mammary gland duct morphogenesis | 100.0% (2/2) | 11.93 | 0.0 | 1e-06 |
| GO:1900208 | regulation of cardiolipin metabolic process | 100.0% (2/2) | 11.93 | 0.0 | 1e-06 |
| GO:0031315 | extrinsic component of mitochondrial outer membrane | 100.0% (2/2) | 11.67 | 0.0 | 1e-06 |
| GO:0033599 | regulation of mammary gland epithelial cell proliferation | 100.0% (2/2) | 11.67 | 0.0 | 1e-06 |
| GO:0010517 | regulation of phospholipase activity | 100.0% (2/2) | 11.55 | 0.0 | 1e-06 |
| GO:0031536 | positive regulation of exit from mitosis | 100.0% (2/2) | 11.55 | 0.0 | 1e-06 |
| GO:0060766 | negative regulation of androgen receptor signaling pathway | 100.0% (2/2) | 11.55 | 0.0 | 1e-06 |
| GO:0098982 | GABA-ergic synapse | 100.0% (2/2) | 11.55 | 0.0 | 1e-06 |
| GO:0032660 | regulation of interleukin-17 production | 100.0% (2/2) | 11.45 | 0.0 | 1e-06 |
| GO:0060191 | regulation of lipase activity | 100.0% (2/2) | 11.25 | 0.0 | 1e-06 |
| GO:0098888 | extrinsic component of presynaptic membrane | 100.0% (2/2) | 11.25 | 0.0 | 1e-06 |
| GO:0007096 | regulation of exit from mitosis | 100.0% (2/2) | 11.17 | 0.0 | 2e-06 |
| GO:0099243 | extrinsic component of synaptic membrane | 100.0% (2/2) | 11.08 | 0.0 | 2e-06 |
| GO:2000027 | regulation of animal organ morphogenesis | 100.0% (2/2) | 11.01 | 0.0 | 2e-06 |
| GO:0000001 | mitochondrion inheritance | 100.0% (2/2) | 10.93 | 0.0 | 2e-06 |
| GO:0002250 | adaptive immune response | 100.0% (2/2) | 10.93 | 0.0 | 2e-06 |
| GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 100.0% (2/2) | 10.93 | 0.0 | 2e-06 |
| GO:0050680 | negative regulation of epithelial cell proliferation | 100.0% (2/2) | 10.86 | 0.0 | 2e-06 |
| GO:0002922 | positive regulation of humoral immune response | 100.0% (2/2) | 10.8 | 0.0 | 2e-06 |
| GO:0046718 | viral entry into host cell | 100.0% (2/2) | 10.8 | 0.0 | 2e-06 |
| GO:0071300 | cellular response to retinoic acid | 100.0% (2/2) | 10.8 | 0.0 | 2e-06 |
| GO:0044409 | entry into host | 100.0% (2/2) | 10.67 | 0.0 | 3e-06 |
| GO:0046625 | sphingolipid binding | 100.0% (2/2) | 10.67 | 0.0 | 3e-06 |
| GO:1904959 | regulation of cytochrome-c oxidase activity | 100.0% (2/2) | 10.67 | 0.0 | 3e-06 |
| GO:0022600 | digestive system process | 100.0% (2/2) | 10.61 | 0.0 | 3e-06 |
| GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway | 100.0% (2/2) | 10.61 | 0.0 | 3e-06 |
| GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 100.0% (2/2) | 10.61 | 0.0 | 3e-06 |
| GO:1904732 | regulation of electron transfer activity | 100.0% (2/2) | 10.61 | 0.0 | 3e-06 |
| GO:0001541 | ovarian follicle development | 100.0% (2/2) | 10.5 | 0.0 | 3e-06 |
| GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 100.0% (2/2) | 10.5 | 0.0 | 3e-06 |
| GO:1901224 | positive regulation of NIK/NF-kappaB signaling | 100.0% (2/2) | 10.5 | 0.0 | 3e-06 |
| GO:0008277 | regulation of G protein-coupled receptor signaling pathway | 100.0% (2/2) | 10.45 | 0.0 | 3e-06 |
| GO:0019054 | modulation by virus of host cellular process | 100.0% (2/2) | 10.45 | 0.0 | 3e-06 |
| GO:0048754 | branching morphogenesis of an epithelial tube | 100.0% (2/2) | 10.45 | 0.0 | 3e-06 |
| GO:0051897 | positive regulation of protein kinase B signaling | 100.0% (2/2) | 10.45 | 0.0 | 3e-06 |
| GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 100.0% (2/2) | 12.67 | 0.0 | 3e-06 |
| GO:0060744 | mammary gland branching involved in thelarche | 100.0% (2/2) | 12.67 | 0.0 | 3e-06 |
| GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 100.0% (2/2) | 12.67 | 0.0 | 3e-06 |
| GO:0044068 | modulation by symbiont of host cellular process | 100.0% (2/2) | 10.4 | 1e-06 | 3e-06 |
| GO:0048308 | organelle inheritance | 100.0% (2/2) | 10.4 | 1e-06 | 3e-06 |
| GO:0007588 | excretion | 100.0% (2/2) | 10.35 | 1e-06 | 3e-06 |
| GO:0044827 | modulation by host of viral genome replication | 100.0% (2/2) | 10.35 | 1e-06 | 3e-06 |
| GO:0002920 | regulation of humoral immune response | 100.0% (2/2) | 10.3 | 1e-06 | 4e-06 |
| GO:0061138 | morphogenesis of a branching epithelium | 100.0% (2/2) | 10.3 | 1e-06 | 4e-06 |
| GO:0098586 | cellular response to virus | 100.0% (2/2) | 10.3 | 1e-06 | 4e-06 |
| GO:0060765 | regulation of androgen receptor signaling pathway | 100.0% (2/2) | 10.21 | 1e-06 | 4e-06 |
| GO:0070741 | response to interleukin-6 | 100.0% (2/2) | 10.17 | 1e-06 | 4e-06 |
| GO:0071354 | cellular response to interleukin-6 | 100.0% (2/2) | 10.17 | 1e-06 | 4e-06 |
| GO:0000422 | autophagy of mitochondrion | 100.0% (2/2) | 10.13 | 1e-06 | 4e-06 |
| GO:0002639 | positive regulation of immunoglobulin production | 100.0% (2/2) | 10.13 | 1e-06 | 4e-06 |
| GO:0061726 | mitochondrion disassembly | 100.0% (2/2) | 10.13 | 1e-06 | 4e-06 |
| GO:0002637 | regulation of immunoglobulin production | 100.0% (2/2) | 10.08 | 1e-06 | 4e-06 |
| GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway | 100.0% (2/2) | 10.08 | 1e-06 | 4e-06 |
| GO:0044788 | modulation by host of viral process | 100.0% (2/2) | 10.08 | 1e-06 | 4e-06 |
| GO:0048311 | mitochondrion distribution | 100.0% (2/2) | 10.08 | 1e-06 | 4e-06 |
| GO:0032526 | response to retinoic acid | 100.0% (2/2) | 10.04 | 1e-06 | 4e-06 |
| GO:0033146 | regulation of intracellular estrogen receptor signaling pathway | 100.0% (2/2) | 10.01 | 1e-06 | 5e-06 |
| GO:0061912 | selective autophagy | 100.0% (2/2) | 9.97 | 1e-06 | 5e-06 |
| GO:1901222 | regulation of NIK/NF-kappaB signaling | 100.0% (2/2) | 9.97 | 1e-06 | 5e-06 |
| GO:0010155 | regulation of proton transport | 100.0% (2/2) | 9.93 | 1e-06 | 5e-06 |
| GO:0051896 | regulation of protein kinase B signaling | 100.0% (2/2) | 9.9 | 1e-06 | 5e-06 |
| GO:0048661 | positive regulation of smooth muscle cell proliferation | 100.0% (2/2) | 9.8 | 1e-06 | 6e-06 |
| GO:0032147 | activation of protein kinase activity | 100.0% (2/2) | 9.76 | 1e-06 | 6e-06 |
| GO:0048660 | regulation of smooth muscle cell proliferation | 100.0% (2/2) | 9.73 | 1e-06 | 6e-06 |
| GO:1902808 | positive regulation of cell cycle G1/S phase transition | 100.0% (2/2) | 9.73 | 1e-06 | 6e-06 |
| GO:0030518 | intracellular steroid hormone receptor signaling pathway | 100.0% (2/2) | 9.67 | 1e-06 | 7e-06 |
| GO:0070372 | regulation of ERK1 and ERK2 cascade | 100.0% (2/2) | 9.67 | 1e-06 | 7e-06 |
| GO:1903725 | regulation of phospholipid metabolic process | 100.0% (2/2) | 9.61 | 2e-06 | 7e-06 |
| GO:0016575 | histone deacetylation | 100.0% (2/2) | 9.53 | 2e-06 | 8e-06 |
| GO:0006476 | protein deacetylation | 100.0% (2/2) | 9.47 | 2e-06 | 9e-06 |
| GO:0019048 | modulation by virus of host process | 100.0% (2/2) | 9.45 | 2e-06 | 9e-06 |
| GO:0005747 | mitochondrial respiratory chain complex I | 100.0% (2/2) | 9.37 | 2e-06 | 1e-05 |
| GO:0030964 | NADH dehydrogenase complex | 100.0% (2/2) | 9.37 | 2e-06 | 1e-05 |
| GO:0045271 | respiratory chain complex I | 100.0% (2/2) | 9.37 | 2e-06 | 1e-05 |
| GO:0050678 | regulation of epithelial cell proliferation | 100.0% (2/2) | 9.35 | 2e-06 | 1e-05 |
| GO:0044003 | modulation by symbiont of host process | 100.0% (2/2) | 9.32 | 2e-06 | 1e-05 |
| GO:0042113 | B cell activation | 100.0% (2/2) | 9.28 | 3e-06 | 1.1e-05 |
| GO:0002702 | positive regulation of production of molecular mediator of immune response | 100.0% (2/2) | 9.15 | 3e-06 | 1.3e-05 |
| GO:0035601 | protein deacylation | 100.0% (2/2) | 9.15 | 3e-06 | 1.3e-05 |
| GO:0007062 | sister chromatid cohesion | 100.0% (2/2) | 9.1 | 3e-06 | 1.3e-05 |
| GO:0051851 | modulation by host of symbiont process | 100.0% (2/2) | 9.1 | 3e-06 | 1.3e-05 |
| GO:0098732 | macromolecule deacylation | 100.0% (2/2) | 9.08 | 3e-06 | 1.4e-05 |
| GO:0035821 | modulation of process of another organism | 100.0% (2/2) | 8.99 | 4e-06 | 1.5e-05 |
| GO:0001664 | G protein-coupled receptor binding | 100.0% (2/2) | 8.97 | 4e-06 | 1.5e-05 |
| GO:0002700 | regulation of production of molecular mediator of immune response | 100.0% (2/2) | 8.97 | 4e-06 | 1.5e-05 |
| GO:0044000 | movement in host | 100.0% (2/2) | 8.97 | 4e-06 | 1.5e-05 |
| GO:0031100 | animal organ regeneration | 100.0% (2/2) | 8.93 | 4e-06 | 1.6e-05 |
| GO:0033143 | regulation of intracellular steroid hormone receptor signaling pathway | 100.0% (2/2) | 8.93 | 4e-06 | 1.6e-05 |
| GO:0047485 | protein N-terminus binding | 100.0% (2/2) | 8.88 | 4e-06 | 1.7e-05 |
| GO:0051646 | mitochondrion localization | 100.0% (2/2) | 8.88 | 4e-06 | 1.7e-05 |
| GO:0006606 | protein import into nucleus | 100.0% (2/2) | 8.83 | 5e-06 | 1.8e-05 |
| GO:0051341 | regulation of oxidoreductase activity | 100.0% (2/2) | 8.83 | 5e-06 | 1.8e-05 |
| GO:0031312 | extrinsic component of organelle membrane | 100.0% (2/2) | 8.81 | 5e-06 | 1.8e-05 |
| GO:0042826 | histone deacetylase binding | 100.0% (2/2) | 8.7 | 6e-06 | 2.1e-05 |
| GO:0098803 | respiratory chain complex | 100.0% (2/2) | 8.67 | 6e-06 | 2.2e-05 |
| GO:0016236 | macroautophagy | 100.0% (2/2) | 8.61 | 6e-06 | 2.3e-05 |
| GO:0016363 | nuclear matrix | 100.0% (2/2) | 8.61 | 6e-06 | 2.3e-05 |
| GO:0043433 | negative regulation of DNA-binding transcription factor activity | 100.0% (2/2) | 8.61 | 6e-06 | 2.3e-05 |
| GO:0043409 | negative regulation of MAPK cascade | 100.0% (2/2) | 8.51 | 7e-06 | 2.6e-05 |
| GO:1903008 | organelle disassembly | 100.0% (2/2) | 8.51 | 7e-06 | 2.6e-05 |
| GO:0045471 | response to ethanol | 100.0% (2/2) | 8.47 | 8e-06 | 2.8e-05 |
| GO:0051170 | import into nucleus | 100.0% (2/2) | 8.45 | 8e-06 | 2.8e-05 |
| GO:1902495 | transmembrane transporter complex | 100.0% (2/2) | 8.45 | 8e-06 | 2.8e-05 |
| GO:0002699 | positive regulation of immune effector process | 100.0% (2/2) | 8.42 | 8e-06 | 2.9e-05 |
| GO:0010508 | positive regulation of autophagy | 100.0% (2/2) | 8.42 | 8e-06 | 2.9e-05 |
| GO:0060688 | regulation of morphogenesis of a branching structure | 100.0% (2/2) | 8.42 | 8e-06 | 2.9e-05 |
| GO:0051091 | positive regulation of DNA-binding transcription factor activity | 100.0% (2/2) | 8.41 | 9e-06 | 2.9e-05 |
| GO:0071897 | DNA biosynthetic process | 100.0% (2/2) | 8.4 | 9e-06 | 2.9e-05 |
| GO:0001819 | positive regulation of cytokine production | 100.0% (2/2) | 8.37 | 9e-06 | 3e-05 |
| GO:1902806 | regulation of cell cycle G1/S phase transition | 100.0% (2/2) | 8.32 | 1e-05 | 3.2e-05 |
| GO:0045860 | positive regulation of protein kinase activity | 100.0% (2/2) | 8.31 | 1e-05 | 3.2e-05 |
| GO:0002697 | regulation of immune effector process | 100.0% (2/2) | 8.28 | 1e-05 | 3.4e-05 |
| GO:0019897 | extrinsic component of plasma membrane | 100.0% (2/2) | 8.27 | 1e-05 | 3.4e-05 |
| GO:0046649 | lymphocyte activation | 100.0% (2/2) | 8.23 | 1.1e-05 | 3.5e-05 |
| GO:0042177 | negative regulation of protein catabolic process | 100.0% (2/2) | 8.21 | 1.1e-05 | 3.6e-05 |
| GO:1901992 | positive regulation of mitotic cell cycle phase transition | 100.0% (2/2) | 8.19 | 1.2e-05 | 3.7e-05 |
| GO:0035239 | tube morphogenesis | 100.0% (2/2) | 8.17 | 1.2e-05 | 3.8e-05 |
| GO:0001763 | morphogenesis of a branching structure | 100.0% (2/2) | 8.14 | 1.3e-05 | 3.9e-05 |
| GO:0030522 | intracellular receptor signaling pathway | 100.0% (2/2) | 8.13 | 1.3e-05 | 3.9e-05 |
| GO:0033674 | positive regulation of kinase activity | 100.0% (2/2) | 8.13 | 1.3e-05 | 3.9e-05 |
| GO:1990351 | transporter complex | 100.0% (2/2) | 8.06 | 1.4e-05 | 4.3e-05 |
| GO:0051701 | biological process involved in interaction with host | 100.0% (2/2) | 8.04 | 1.4e-05 | 4.4e-05 |
| GO:0003714 | transcription corepressor activity | 100.0% (2/2) | 8.02 | 1.5e-05 | 4.5e-05 |
| GO:0045321 | leukocyte activation | 100.0% (2/2) | 8.02 | 1.5e-05 | 4.5e-05 |
| GO:0008022 | protein C-terminus binding | 100.0% (2/2) | 7.97 | 1.6e-05 | 4.7e-05 |
| GO:0098800 | inner mitochondrial membrane protein complex | 100.0% (2/2) | 7.96 | 1.6e-05 | 4.8e-05 |
| GO:1901989 | positive regulation of cell cycle phase transition | 100.0% (2/2) | 7.92 | 1.7e-05 | 5e-05 |
| GO:0001775 | cell activation | 100.0% (2/2) | 7.9 | 1.7e-05 | 5.2e-05 |
| GO:0002009 | morphogenesis of an epithelium | 100.0% (2/2) | 7.85 | 1.9e-05 | 5.4e-05 |
| GO:0045931 | positive regulation of mitotic cell cycle | 100.0% (2/2) | 7.85 | 1.9e-05 | 5.4e-05 |
| GO:1990204 | oxidoreductase complex | 100.0% (2/2) | 7.84 | 1.9e-05 | 5.5e-05 |
| GO:0014069 | postsynaptic density | 100.0% (2/2) | 7.8 | 2e-05 | 5.8e-05 |
| GO:0099572 | postsynaptic specialization | 100.0% (2/2) | 7.8 | 2e-05 | 5.8e-05 |
| GO:0009986 | cell surface | 100.0% (2/2) | 7.78 | 2.1e-05 | 5.9e-05 |
| GO:0031099 | regeneration | 100.0% (2/2) | 7.76 | 2.1e-05 | 6e-05 |
| GO:0030424 | axon | 100.0% (2/2) | 7.74 | 2.2e-05 | 6.1e-05 |
| GO:0001817 | regulation of cytokine production | 100.0% (2/2) | 7.72 | 2.2e-05 | 6.2e-05 |
| GO:0043410 | positive regulation of MAPK cascade | 100.0% (2/2) | 7.72 | 2.2e-05 | 6.2e-05 |
| GO:0051345 | positive regulation of hydrolase activity | 100.0% (2/2) | 7.68 | 2.4e-05 | 6.6e-05 |
| GO:0030308 | negative regulation of cell growth | 100.0% (2/2) | 7.63 | 2.5e-05 | 7e-05 |
| GO:0034504 | protein localization to nucleus | 100.0% (2/2) | 7.6 | 2.6e-05 | 7.2e-05 |
| GO:0048729 | tissue morphogenesis | 100.0% (2/2) | 7.6 | 2.6e-05 | 7.2e-05 |
| GO:0098978 | glutamatergic synapse | 100.0% (2/2) | 7.59 | 2.7e-05 | 7.3e-05 |
| GO:0043401 | steroid hormone mediated signaling pathway | 100.0% (2/2) | 7.51 | 3e-05 | 8e-05 |
| GO:0043434 | response to peptide hormone | 100.0% (2/2) | 7.5 | 3e-05 | 8.1e-05 |
| GO:0043467 | regulation of generation of precursor metabolites and energy | 100.0% (2/2) | 7.47 | 3.2e-05 | 8.4e-05 |
| GO:0016477 | cell migration | 100.0% (2/2) | 7.47 | 3.2e-05 | 8.4e-05 |
| GO:0005769 | early endosome | 100.0% (2/2) | 7.42 | 3.4e-05 | 8.8e-05 |
| GO:0006914 | autophagy | 100.0% (2/2) | 7.42 | 3.4e-05 | 8.8e-05 |
| GO:0016032 | viral process | 100.0% (2/2) | 7.42 | 3.4e-05 | 8.8e-05 |
| GO:0051090 | regulation of DNA-binding transcription factor activity | 100.0% (2/2) | 7.4 | 3.5e-05 | 9e-05 |
| GO:1904062 | regulation of cation transmembrane transport | 100.0% (2/2) | 7.4 | 3.5e-05 | 9e-05 |
| GO:0061919 | process utilizing autophagic mechanism | 100.0% (2/2) | 7.4 | 3.5e-05 | 9e-05 |
| GO:0010506 | regulation of autophagy | 100.0% (2/2) | 7.37 | 3.7e-05 | 9.3e-05 |
| GO:0001934 | positive regulation of protein phosphorylation | 100.0% (2/2) | 7.35 | 3.7e-05 | 9.4e-05 |
| GO:0051347 | positive regulation of transferase activity | 100.0% (2/2) | 7.35 | 3.7e-05 | 9.4e-05 |
| GO:0006913 | nucleocytoplasmic transport | 100.0% (2/2) | 7.34 | 3.8e-05 | 9.5e-05 |
| GO:0050821 | protein stabilization | 100.0% (2/2) | 7.34 | 3.8e-05 | 9.5e-05 |
| GO:0098798 | mitochondrial protein-containing complex | 100.0% (2/2) | 7.34 | 3.8e-05 | 9.5e-05 |
| GO:0051169 | nuclear transport | 100.0% (2/2) | 7.33 | 3.8e-05 | 9.5e-05 |
| GO:0045861 | negative regulation of proteolysis | 100.0% (2/2) | 7.32 | 3.9e-05 | 9.6e-05 |
| GO:0007005 | mitochondrion organization | 100.0% (2/2) | 7.26 | 4.2e-05 | 0.000104 |
| GO:0048870 | cell motility | 100.0% (2/2) | 7.22 | 4.5e-05 | 0.000109 |
| GO:0042327 | positive regulation of phosphorylation | 100.0% (2/2) | 7.2 | 4.6e-05 | 0.000112 |
| GO:0071345 | cellular response to cytokine stimulus | 100.0% (2/2) | 7.18 | 4.8e-05 | 0.000115 |
| GO:0090068 | positive regulation of cell cycle process | 100.0% (2/2) | 7.17 | 4.8e-05 | 0.000116 |
| GO:0043408 | regulation of MAPK cascade | 100.0% (2/2) | 7.11 | 5.2e-05 | 0.000124 |
| GO:0002221 | pattern recognition receptor signaling pathway | 100.0% (2/2) | 7.09 | 5.4e-05 | 0.000128 |
| GO:0045859 | regulation of protein kinase activity | 100.0% (2/2) | 7.08 | 5.4e-05 | 0.000128 |
| GO:0019898 | extrinsic component of membrane | 100.0% (2/2) | 7.04 | 5.8e-05 | 0.000137 |
| GO:1901652 | response to peptide | 100.0% (2/2) | 7.02 | 5.9e-05 | 0.000139 |
| GO:0051607 | defense response to virus | 100.0% (2/2) | 6.99 | 6.2e-05 | 0.000144 |
| GO:0140546 | defense response to symbiont | 100.0% (2/2) | 6.99 | 6.2e-05 | 0.000144 |
| GO:0046982 | protein heterodimerization activity | 100.0% (2/2) | 6.96 | 6.4e-05 | 0.000148 |
| GO:0043549 | regulation of kinase activity | 100.0% (2/2) | 6.96 | 6.4e-05 | 0.000148 |
| GO:0010562 | positive regulation of phosphorus metabolic process | 100.0% (2/2) | 6.94 | 6.6e-05 | 0.000152 |
| GO:0045937 | positive regulation of phosphate metabolic process | 100.0% (2/2) | 6.94 | 6.6e-05 | 0.000152 |
| GO:0008285 | negative regulation of cell population proliferation | 100.0% (2/2) | 6.92 | 6.8e-05 | 0.000155 |
| GO:0022411 | cellular component disassembly | 100.0% (2/2) | 6.91 | 6.9e-05 | 0.000156 |
| GO:0032412 | regulation of ion transmembrane transporter activity | 100.0% (2/2) | 6.91 | 6.9e-05 | 0.000156 |
| GO:0009895 | negative regulation of catabolic process | 100.0% (2/2) | 6.9 | 7e-05 | 0.000157 |
| GO:0022898 | regulation of transmembrane transporter activity | 100.0% (2/2) | 6.9 | 7e-05 | 0.000157 |
| GO:0032409 | regulation of transporter activity | 100.0% (2/2) | 6.87 | 7.3e-05 | 0.000162 |
| GO:0071456 | cellular response to hypoxia | 100.0% (2/2) | 6.86 | 7.4e-05 | 0.000163 |
| GO:0006457 | protein folding | 100.0% (2/2) | 6.85 | 7.5e-05 | 0.000165 |
| GO:1901990 | regulation of mitotic cell cycle phase transition | 100.0% (2/2) | 6.85 | 7.5e-05 | 0.000166 |
| GO:0005887 | integral component of plasma membrane | 100.0% (2/2) | 6.83 | 7.7e-05 | 0.000168 |
| GO:0036294 | cellular response to decreased oxygen levels | 100.0% (2/2) | 6.83 | 7.7e-05 | 0.000168 |
| GO:0034097 | response to cytokine | 100.0% (2/2) | 6.81 | 7.9e-05 | 0.000172 |
| GO:0071453 | cellular response to oxygen levels | 100.0% (2/2) | 6.7 | 9.2e-05 | 0.000198 |
| GO:0045787 | positive regulation of cell cycle | 100.0% (2/2) | 6.68 | 9.5e-05 | 0.000203 |
| GO:0031647 | regulation of protein stability | 100.0% (2/2) | 6.66 | 9.7e-05 | 0.000208 |
| GO:0033218 | amide binding | 100.0% (2/2) | 6.6 | 0.000106 | 0.000225 |
| GO:0045926 | negative regulation of growth | 100.0% (2/2) | 6.57 | 0.00011 | 0.000234 |
| GO:0034765 | regulation of ion transmembrane transport | 100.0% (2/2) | 6.56 | 0.000111 | 0.000235 |
| GO:0042176 | regulation of protein catabolic process | 100.0% (2/2) | 6.53 | 0.000117 | 0.000246 |
| GO:0071396 | cellular response to lipid | 100.0% (2/2) | 6.53 | 0.000117 | 0.000246 |
| GO:1902532 | negative regulation of intracellular signal transduction | 100.0% (2/2) | 6.51 | 0.00012 | 0.000249 |
| GO:1901987 | regulation of cell cycle phase transition | 100.0% (2/2) | 6.49 | 0.000124 | 0.000256 |
| GO:1902533 | positive regulation of intracellular signal transduction | 100.0% (2/2) | 6.48 | 0.000125 | 0.000259 |
| GO:0000122 | negative regulation of transcription by RNA polymerase II | 100.0% (2/2) | 6.46 | 0.000128 | 0.000264 |
| GO:0031331 | positive regulation of cellular catabolic process | 100.0% (2/2) | 6.46 | 0.000129 | 0.000264 |
| GO:0072594 | establishment of protein localization to organelle | 100.0% (2/2) | 6.44 | 0.000132 | 0.00027 |
| GO:0043066 | negative regulation of apoptotic process | 100.0% (2/2) | 6.44 | 0.000133 | 0.00027 |
| GO:0034762 | regulation of transmembrane transport | 100.0% (2/2) | 6.42 | 0.000136 | 0.000275 |
| GO:0051336 | regulation of hydrolase activity | 100.0% (2/2) | 6.42 | 0.000137 | 0.000276 |
| GO:0003712 | transcription coregulator activity | 100.0% (2/2) | 6.38 | 0.000144 | 0.000288 |
| GO:0051338 | regulation of transferase activity | 100.0% (2/2) | 6.36 | 0.000148 | 0.000296 |
| GO:0008284 | positive regulation of cell population proliferation | 100.0% (2/2) | 6.32 | 0.000157 | 0.000312 |
| GO:0007166 | cell surface receptor signaling pathway | 100.0% (2/2) | 6.31 | 0.000157 | 0.000312 |
| GO:0001932 | regulation of protein phosphorylation | 100.0% (2/2) | 6.31 | 0.000159 | 0.000315 |
| GO:0007346 | regulation of mitotic cell cycle | 100.0% (2/2) | 6.29 | 0.000164 | 0.000321 |
| GO:0043085 | positive regulation of catalytic activity | 100.0% (2/2) | 6.29 | 0.000164 | 0.000321 |
| GO:0005102 | signaling receptor binding | 100.0% (2/2) | 6.28 | 0.000166 | 0.000323 |
| GO:0051276 | chromosome organization | 100.0% (2/2) | 6.28 | 0.000166 | 0.000323 |
| GO:0009615 | response to virus | 100.0% (2/2) | 6.25 | 0.000173 | 0.000334 |
| GO:0045202 | synapse | 100.0% (2/2) | 6.21 | 0.000182 | 0.000352 |
| GO:0043069 | negative regulation of programmed cell death | 100.0% (2/2) | 6.19 | 0.000187 | 0.00036 |
| GO:0010942 | positive regulation of cell death | 100.0% (2/2) | 6.19 | 0.000188 | 0.000361 |
| GO:0043005 | neuron projection | 100.0% (2/2) | 6.18 | 0.000191 | 0.000363 |
| GO:0051640 | organelle localization | 100.0% (2/2) | 6.17 | 0.000192 | 0.000365 |
| GO:0016570 | histone modification | 100.0% (2/2) | 6.17 | 0.000193 | 0.000366 |
| GO:0009896 | positive regulation of catabolic process | 100.0% (2/2) | 6.16 | 0.000195 | 0.000369 |
| GO:0002764 | immune response-regulating signaling pathway | 100.0% (2/2) | 6.12 | 0.000206 | 0.000385 |
| GO:0051702 | biological process involved in interaction with symbiont | 100.0% (2/2) | 6.12 | 0.000206 | 0.000385 |
| GO:0042325 | regulation of phosphorylation | 100.0% (2/2) | 6.09 | 0.000214 | 0.000399 |
| GO:0030162 | regulation of proteolysis | 100.0% (2/2) | 6.09 | 0.000215 | 0.0004 |
| GO:0043269 | regulation of ion transport | 100.0% (2/2) | 6.06 | 0.000224 | 0.000414 |
| GO:0031401 | positive regulation of protein modification process | 100.0% (2/2) | 6.06 | 0.000224 | 0.000414 |
| GO:0001666 | response to hypoxia | 100.0% (2/2) | 6.05 | 0.000227 | 0.000418 |
| GO:0008289 | lipid binding | 100.0% (2/2) | 6.0 | 0.000244 | 0.000447 |
| GO:0031226 | intrinsic component of plasma membrane | 100.0% (2/2) | 5.98 | 0.00025 | 0.000457 |
| GO:0036293 | response to decreased oxygen levels | 100.0% (2/2) | 5.96 | 0.000257 | 0.000467 |
| GO:0060548 | negative regulation of cell death | 100.0% (2/2) | 5.91 | 0.000274 | 0.000497 |
| GO:0019216 | regulation of lipid metabolic process | 100.0% (2/2) | 5.9 | 0.000281 | 0.000507 |
| GO:0070482 | response to oxygen levels | 100.0% (2/2) | 5.88 | 0.000286 | 0.000515 |
| GO:0003008 | system process | 100.0% (2/2) | 5.79 | 0.000325 | 0.000582 |
| GO:0042981 | regulation of apoptotic process | 100.0% (2/2) | 5.73 | 0.000352 | 0.000629 |
| GO:0010564 | regulation of cell cycle process | 100.0% (2/2) | 5.71 | 0.000364 | 0.000645 |
| GO:0019220 | regulation of phosphate metabolic process | 100.0% (2/2) | 5.71 | 0.000364 | 0.000645 |
| GO:0050778 | positive regulation of immune response | 100.0% (2/2) | 5.7 | 0.000368 | 0.000649 |
| GO:0051174 | regulation of phosphorus metabolic process | 100.0% (2/2) | 5.69 | 0.000376 | 0.000661 |
| GO:0044092 | negative regulation of molecular function | 100.0% (2/2) | 5.68 | 0.000382 | 0.000667 |
| GO:0098796 | membrane protein complex | 100.0% (2/2) | 5.68 | 0.000381 | 0.000667 |
| GO:0033365 | protein localization to organelle | 100.0% (2/2) | 5.64 | 0.000403 | 0.000701 |
| GO:0031329 | regulation of cellular catabolic process | 100.0% (2/2) | 5.62 | 0.000413 | 0.000717 |
| GO:0034654 | nucleobase-containing compound biosynthetic process | 100.0% (2/2) | 5.61 | 0.000418 | 0.000723 |
| GO:0044093 | positive regulation of molecular function | 100.0% (2/2) | 5.57 | 0.000442 | 0.000761 |
| GO:0001558 | regulation of cell growth | 100.0% (2/2) | 5.57 | 0.000444 | 0.000762 |
| GO:0006886 | intracellular protein transport | 100.0% (2/2) | 5.56 | 0.000446 | 0.000763 |
| GO:0002684 | positive regulation of immune system process | 100.0% (2/2) | 5.51 | 0.000478 | 0.000815 |
| GO:0051248 | negative regulation of protein metabolic process | 100.0% (2/2) | 5.5 | 0.00049 | 0.000833 |
| GO:0044403 | biological process involved in symbiotic interaction | 100.0% (2/2) | 5.46 | 0.000513 | 0.000869 |
| GO:0010628 | positive regulation of gene expression | 100.0% (2/2) | 5.41 | 0.000553 | 0.000934 |
| GO:0042127 | regulation of cell population proliferation | 100.0% (2/2) | 5.38 | 0.000574 | 0.000966 |
| GO:0051241 | negative regulation of multicellular organismal process | 100.0% (2/2) | 5.27 | 0.00067 | 0.001123 |
| GO:0009894 | regulation of catabolic process | 100.0% (2/2) | 5.27 | 0.000675 | 0.001124 |
| GO:1902531 | regulation of intracellular signal transduction | 100.0% (2/2) | 5.27 | 0.000675 | 0.001124 |
| GO:0045087 | innate immune response | 100.0% (2/2) | 5.25 | 0.000687 | 0.00114 |
| GO:0051247 | positive regulation of protein metabolic process | 100.0% (2/2) | 5.2 | 0.000735 | 0.001216 |
| GO:0009967 | positive regulation of signal transduction | 100.0% (2/2) | 5.19 | 0.000747 | 0.001232 |
| GO:0051240 | positive regulation of multicellular organismal process | 100.0% (2/2) | 5.19 | 0.000751 | 0.001235 |
| GO:0006259 | DNA metabolic process | 100.0% (2/2) | 5.16 | 0.000778 | 0.001275 |
| GO:0051726 | regulation of cell cycle | 100.0% (2/2) | 5.15 | 0.000791 | 0.001292 |
| GO:0043067 | regulation of programmed cell death | 100.0% (2/2) | 5.15 | 0.000797 | 0.001297 |
| GO:0048513 | animal organ development | 100.0% (2/2) | 5.14 | 0.000801 | 0.0013 |
| GO:0006955 | immune response | 100.0% (2/2) | 5.13 | 0.00081 | 0.001306 |
| GO:0031399 | regulation of protein modification process | 100.0% (2/2) | 5.13 | 0.00081 | 0.001306 |
| GO:0022603 | regulation of anatomical structure morphogenesis | 100.0% (2/2) | 5.12 | 0.000825 | 0.001325 |
| GO:0015031 | protein transport | 100.0% (2/2) | 5.1 | 0.000847 | 0.001356 |
| GO:0023056 | positive regulation of signaling | 100.0% (2/2) | 5.08 | 0.000872 | 0.001392 |
| GO:0010647 | positive regulation of cell communication | 100.0% (2/2) | 5.06 | 0.000894 | 0.001422 |
| GO:0042803 | protein homodimerization activity | 100.0% (2/2) | 5.02 | 0.00095 | 0.001506 |
| GO:0045184 | establishment of protein localization | 100.0% (2/2) | 5.01 | 0.000961 | 0.001519 |
| GO:0120025 | plasma membrane bounded cell projection | 100.0% (2/2) | 4.99 | 0.000985 | 0.001552 |
| GO:0035556 | intracellular signal transduction | 100.0% (2/2) | 4.98 | 0.001009 | 0.001585 |
| GO:0009968 | negative regulation of signal transduction | 100.0% (2/2) | 4.94 | 0.001058 | 0.001657 |
| GO:0045892 | negative regulation of DNA-templated transcription | 100.0% (2/2) | 4.94 | 0.001065 | 0.001662 |
| GO:1902679 | negative regulation of RNA biosynthetic process | 100.0% (2/2) | 4.93 | 0.001082 | 0.001678 |
| GO:1903507 | negative regulation of nucleic acid-templated transcription | 100.0% (2/2) | 4.93 | 0.001082 | 0.001678 |
| GO:0050790 | regulation of catalytic activity | 100.0% (2/2) | 4.92 | 0.001093 | 0.001691 |
| GO:0010648 | negative regulation of cell communication | 100.0% (2/2) | 4.89 | 0.001133 | 0.001736 |
| GO:0010941 | regulation of cell death | 100.0% (2/2) | 4.89 | 0.001131 | 0.001738 |
| GO:0023057 | negative regulation of signaling | 100.0% (2/2) | 4.89 | 0.001129 | 0.001741 |
| GO:0042995 | cell projection | 100.0% (2/2) | 4.87 | 0.001164 | 0.001778 |
| GO:0046907 | intracellular transport | 100.0% (2/2) | 4.85 | 0.001201 | 0.001829 |
| GO:0005768 | endosome | 100.0% (2/2) | 4.84 | 0.00122 | 0.001853 |
| GO:1901701 | cellular response to oxygen-containing compound | 100.0% (2/2) | 4.81 | 0.001271 | 0.001924 |
| GO:0006357 | regulation of transcription by RNA polymerase II | 100.0% (2/2) | 4.79 | 0.001298 | 0.00196 |
| GO:0009611 | response to wounding | 100.0% (2/2) | 4.78 | 0.001324 | 0.001993 |
| GO:0051253 | negative regulation of RNA metabolic process | 100.0% (2/2) | 4.77 | 0.001341 | 0.002012 |
| GO:0050776 | regulation of immune response | 100.0% (2/2) | 4.76 | 0.001353 | 0.002023 |
| GO:0022402 | cell cycle process | 100.0% (2/2) | 4.71 | 0.001464 | 0.002183 |
| GO:0051049 | regulation of transport | 100.0% (2/2) | 4.69 | 0.001503 | 0.002235 |
| GO:0009059 | macromolecule biosynthetic process | 100.0% (2/2) | 4.67 | 0.001539 | 0.002281 |
| GO:0010558 | negative regulation of macromolecule biosynthetic process | 100.0% (2/2) | 4.64 | 0.001602 | 0.002367 |
| GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 100.0% (2/2) | 4.64 | 0.001614 | 0.002379 |
| GO:0046983 | protein dimerization activity | 100.0% (2/2) | 4.63 | 0.001633 | 0.002392 |
| GO:0006979 | response to oxidative stress | 100.0% (2/2) | 4.63 | 0.001629 | 0.002393 |
| GO:0051649 | establishment of localization in cell | 100.0% (2/2) | 4.63 | 0.001641 | 0.002397 |
| GO:0071310 | cellular response to organic substance | 100.0% (2/2) | 4.62 | 0.001647 | 0.002399 |
| GO:0002682 | regulation of immune system process | 100.0% (2/2) | 4.55 | 0.001826 | 0.002636 |
| GO:0031327 | negative regulation of cellular biosynthetic process | 100.0% (2/2) | 4.55 | 0.001824 | 0.002641 |
| GO:0008104 | protein localization | 100.0% (2/2) | 4.55 | 0.00182 | 0.002642 |
| GO:0010243 | response to organonitrogen compound | 100.0% (2/2) | 4.53 | 0.00187 | 0.002692 |
| GO:0009890 | negative regulation of biosynthetic process | 100.0% (2/2) | 4.51 | 0.001917 | 0.002752 |
| GO:0009755 | hormone-mediated signaling pathway | 100.0% (2/2) | 4.46 | 0.002056 | 0.002934 |
| GO:0018130 | heterocycle biosynthetic process | 100.0% (2/2) | 4.46 | 0.002054 | 0.002939 |
| GO:0005654 | nucleoplasm | 100.0% (2/2) | 4.45 | 0.002084 | 0.002966 |
| GO:0002376 | immune system process | 100.0% (2/2) | 4.43 | 0.002143 | 0.003041 |
| GO:0040008 | regulation of growth | 100.0% (2/2) | 4.42 | 0.002196 | 0.003097 |
| GO:0005618 | cell wall | 100.0% (2/2) | 4.42 | 0.002191 | 0.003099 |
| GO:0045893 | positive regulation of DNA-templated transcription | 100.0% (2/2) | 4.41 | 0.002224 | 0.003129 |
| GO:0070727 | cellular macromolecule localization | 100.0% (2/2) | 4.4 | 0.002256 | 0.003165 |
| GO:1902680 | positive regulation of RNA biosynthetic process | 100.0% (2/2) | 4.39 | 0.00227 | 0.003167 |
| GO:1903508 | positive regulation of nucleic acid-templated transcription | 100.0% (2/2) | 4.39 | 0.002266 | 0.003169 |
| GO:0032879 | regulation of localization | 100.0% (2/2) | 4.38 | 0.002297 | 0.003196 |
| GO:1902494 | catalytic complex | 100.0% (2/2) | 4.36 | 0.002364 | 0.003279 |
| GO:0097305 | response to alcohol | 100.0% (2/2) | 4.36 | 0.002382 | 0.003285 |
| GO:1901698 | response to nitrogen compound | 100.0% (2/2) | 4.36 | 0.002382 | 0.003285 |
| GO:0030312 | external encapsulating structure | 100.0% (2/2) | 4.33 | 0.002454 | 0.003358 |
| GO:0005774 | vacuolar membrane | 100.0% (2/2) | 4.34 | 0.002442 | 0.003359 |
| GO:0071705 | nitrogen compound transport | 100.0% (2/2) | 4.34 | 0.002452 | 0.003364 |
| GO:0044271 | cellular nitrogen compound biosynthetic process | 100.0% (2/2) | 4.33 | 0.002467 | 0.003366 |
| GO:0065009 | regulation of molecular function | 100.0% (2/2) | 4.27 | 0.002688 | 0.003657 |
| GO:0031410 | cytoplasmic vesicle | 100.0% (2/2) | 4.26 | 0.00272 | 0.003691 |
| GO:0051254 | positive regulation of RNA metabolic process | 100.0% (2/2) | 4.24 | 0.002784 | 0.003768 |
| GO:0033036 | macromolecule localization | 100.0% (2/2) | 4.24 | 0.002806 | 0.003787 |
| GO:0097708 | intracellular vesicle | 100.0% (2/2) | 4.22 | 0.002877 | 0.003872 |
| GO:0140110 | transcription regulator activity | 100.0% (2/2) | 4.21 | 0.002929 | 0.003932 |
| GO:0019899 | enzyme binding | 100.0% (2/2) | 4.19 | 0.003004 | 0.004022 |
| GO:0010557 | positive regulation of macromolecule biosynthetic process | 100.0% (2/2) | 4.18 | 0.003058 | 0.004083 |
| GO:0051246 | regulation of protein metabolic process | 100.0% (2/2) | 4.17 | 0.003072 | 0.004091 |
| GO:0048585 | negative regulation of response to stimulus | 100.0% (2/2) | 4.14 | 0.003236 | 0.004297 |
| GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 100.0% (2/2) | 4.13 | 0.003259 | 0.004317 |
| GO:0051128 | regulation of cellular component organization | 100.0% (2/2) | 4.11 | 0.003365 | 0.004445 |
| GO:0019438 | aromatic compound biosynthetic process | 100.0% (2/2) | 4.1 | 0.003413 | 0.004496 |
| GO:0051641 | cellular localization | 100.0% (2/2) | 4.08 | 0.003488 | 0.004559 |
| GO:0009536 | plastid | 100.0% (2/2) | 4.08 | 0.003482 | 0.004563 |
| GO:0031982 | vesicle | 100.0% (2/2) | 4.08 | 0.003473 | 0.004563 |
| GO:0031324 | negative regulation of cellular metabolic process | 100.0% (2/2) | 4.07 | 0.003549 | 0.004626 |
| GO:0071702 | organic substance transport | 100.0% (2/2) | 4.07 | 0.003561 | 0.00463 |
| GO:0051172 | negative regulation of nitrogen compound metabolic process | 100.0% (2/2) | 4.05 | 0.003662 | 0.00475 |
| GO:0031328 | positive regulation of cellular biosynthetic process | 100.0% (2/2) | 4.0 | 0.003911 | 0.005059 |
| GO:0009891 | positive regulation of biosynthetic process | 100.0% (2/2) | 3.97 | 0.00405 | 0.005225 |
| GO:0048584 | positive regulation of response to stimulus | 100.0% (2/2) | 3.94 | 0.004214 | 0.005423 |
| GO:0044248 | cellular catabolic process | 100.0% (2/2) | 3.86 | 0.004759 | 0.006108 |
| GO:1901362 | organic cyclic compound biosynthetic process | 100.0% (2/2) | 3.82 | 0.005038 | 0.00645 |
| GO:0009966 | regulation of signal transduction | 100.0% (2/2) | 3.79 | 0.005225 | 0.006672 |
| GO:0010605 | negative regulation of macromolecule metabolic process | 100.0% (2/2) | 3.78 | 0.005292 | 0.00674 |
| GO:0070887 | cellular response to chemical stimulus | 100.0% (2/2) | 3.73 | 0.005652 | 0.00718 |
| GO:0042802 | identical protein binding | 100.0% (2/2) | 3.7 | 0.005928 | 0.007512 |
| GO:0023051 | regulation of signaling | 100.0% (2/2) | 3.68 | 0.006055 | 0.007634 |
| GO:0006996 | organelle organization | 100.0% (2/2) | 3.68 | 0.006079 | 0.007644 |
| GO:0009506 | plasmodesma | 100.0% (2/2) | 3.68 | 0.006095 | 0.007645 |
| GO:0051173 | positive regulation of nitrogen compound metabolic process | 100.0% (2/2) | 3.68 | 0.006051 | 0.007648 |
| GO:0098588 | bounding membrane of organelle | 100.0% (2/2) | 3.68 | 0.006127 | 0.007666 |
| GO:0010646 | regulation of cell communication | 100.0% (2/2) | 3.67 | 0.006143 | 0.007667 |
| GO:0005911 | cell-cell junction | 100.0% (2/2) | 3.64 | 0.00641 | 0.007981 |
| GO:0016021 | integral component of membrane | 100.0% (2/2) | 3.64 | 0.006431 | 0.007986 |
| GO:0051239 | regulation of multicellular organismal process | 100.0% (2/2) | 3.64 | 0.006451 | 0.007992 |
| GO:0009892 | negative regulation of metabolic process | 100.0% (2/2) | 3.63 | 0.006492 | 0.008023 |
| GO:0070161 | anchoring junction | 100.0% (2/2) | 3.63 | 0.006509 | 0.008023 |
| GO:0090304 | nucleic acid metabolic process | 100.0% (2/2) | 3.6 | 0.006801 | 0.008363 |
| GO:0031325 | positive regulation of cellular metabolic process | 100.0% (2/2) | 3.59 | 0.006856 | 0.00841 |
| GO:0010604 | positive regulation of macromolecule metabolic process | 100.0% (2/2) | 3.58 | 0.007009 | 0.008577 |
| GO:0009056 | catabolic process | 100.0% (2/2) | 3.55 | 0.007238 | 0.008835 |
| GO:0044260 | cellular macromolecule metabolic process | 100.0% (2/2) | 3.51 | 0.007685 | 0.009357 |
| GO:0033993 | response to lipid | 100.0% (2/2) | 3.5 | 0.007806 | 0.009482 |
| GO:0009653 | anatomical structure morphogenesis | 100.0% (2/2) | 3.49 | 0.00792 | 0.009596 |
| GO:0006355 | regulation of DNA-templated transcription | 100.0% (2/2) | 3.47 | 0.008098 | 0.009789 |
| GO:2001141 | regulation of RNA biosynthetic process | 100.0% (2/2) | 3.47 | 0.008154 | 0.009808 |
| GO:1903506 | regulation of nucleic acid-templated transcription | 100.0% (2/2) | 3.47 | 0.008144 | 0.009821 |
| GO:0031224 | intrinsic component of membrane | 100.0% (2/2) | 3.45 | 0.008424 | 0.010109 |
| GO:0030054 | cell junction | 100.0% (2/2) | 3.43 | 0.008594 | 0.010288 |
| GO:0033554 | cellular response to stress | 100.0% (2/2) | 3.4 | 0.008953 | 0.010692 |
| GO:0009893 | positive regulation of metabolic process | 100.0% (2/2) | 3.37 | 0.00929 | 0.011068 |
| GO:0051252 | regulation of RNA metabolic process | 100.0% (2/2) | 3.34 | 0.009805 | 0.011654 |
| GO:0006139 | nucleobase-containing compound metabolic process | 100.0% (2/2) | 3.31 | 0.010194 | 0.012087 |
| GO:0036211 | protein modification process | 100.0% (2/2) | 3.3 | 0.010355 | 0.012249 |
| GO:0007165 | signal transduction | 100.0% (2/2) | 3.26 | 0.010866 | 0.012823 |
| GO:0010556 | regulation of macromolecule biosynthetic process | 100.0% (2/2) | 3.23 | 0.011368 | 0.013383 |
| GO:0019219 | regulation of nucleobase-containing compound metabolic process | 100.0% (2/2) | 3.22 | 0.011593 | 0.013616 |
| GO:0050793 | regulation of developmental process | 100.0% (2/2) | 3.18 | 0.012229 | 0.01433 |
| GO:0006810 | transport | 100.0% (2/2) | 3.17 | 0.012308 | 0.014389 |
| GO:0098542 | defense response to other organism | 100.0% (2/2) | 3.17 | 0.012399 | 0.014461 |
| GO:0048523 | negative regulation of cellular process | 100.0% (2/2) | 3.16 | 0.012542 | 0.014594 |
| GO:0009725 | response to hormone | 100.0% (2/2) | 3.16 | 0.0126 | 0.014626 |
| GO:0065008 | regulation of biological quality | 100.0% (2/2) | 3.11 | 0.013322 | 0.015429 |
| GO:0051234 | establishment of localization | 100.0% (2/2) | 3.11 | 0.013446 | 0.015536 |
| GO:0043412 | macromolecule modification | 100.0% (2/2) | 3.06 | 0.014339 | 0.016529 |
| GO:0009719 | response to endogenous stimulus | 100.0% (2/2) | 3.06 | 0.014412 | 0.016576 |
| GO:0032991 | protein-containing complex | 100.0% (2/2) | 3.02 | 0.015279 | 0.017532 |
| GO:0031326 | regulation of cellular biosynthetic process | 100.0% (2/2) | 3.01 | 0.015348 | 0.017571 |
| GO:0010468 | regulation of gene expression | 100.0% (2/2) | 2.96 | 0.016399 | 0.018688 |
| GO:0009889 | regulation of biosynthetic process | 100.0% (2/2) | 2.97 | 0.016366 | 0.018694 |
| GO:0031090 | organelle membrane | 100.0% (2/2) | 2.96 | 0.016478 | 0.018735 |
| GO:0046483 | heterocycle metabolic process | 100.0% (2/2) | 2.92 | 0.017336 | 0.019666 |
| GO:0051179 | localization | 100.0% (2/2) | 2.9 | 0.017845 | 0.020197 |
| GO:0019538 | protein metabolic process | 100.0% (2/2) | 2.89 | 0.018099 | 0.020438 |
| GO:0006952 | defense response | 100.0% (2/2) | 2.89 | 0.018237 | 0.020547 |
| GO:0048583 | regulation of response to stimulus | 100.0% (2/2) | 2.88 | 0.018347 | 0.020625 |
| GO:0034641 | cellular nitrogen compound metabolic process | 100.0% (2/2) | 2.87 | 0.018591 | 0.020852 |
| GO:0048522 | positive regulation of cellular process | 100.0% (2/2) | 2.85 | 0.019139 | 0.021418 |
| GO:0044249 | cellular biosynthetic process | 100.0% (2/2) | 2.83 | 0.019645 | 0.021935 |
| GO:0003006 | developmental process involved in reproduction | 100.0% (2/2) | 2.81 | 0.020201 | 0.022506 |
| GO:0051171 | regulation of nitrogen compound metabolic process | 100.0% (2/2) | 2.78 | 0.02118 | 0.023544 |
| GO:0051716 | cellular response to stimulus | 100.0% (2/2) | 2.76 | 0.021689 | 0.024056 |
| GO:1901576 | organic substance biosynthetic process | 100.0% (2/2) | 2.75 | 0.022113 | 0.024472 |
| GO:0051707 | response to other organism | 100.0% (2/2) | 2.74 | 0.02238 | 0.024713 |
| GO:0006725 | cellular aromatic compound metabolic process | 100.0% (2/2) | 2.73 | 0.022757 | 0.025073 |
| GO:0048519 | negative regulation of biological process | 100.0% (2/2) | 2.7 | 0.023543 | 0.025882 |
| GO:0044419 | biological process involved in interspecies interaction between organisms | 100.0% (2/2) | 2.7 | 0.023693 | 0.025989 |
| GO:0080090 | regulation of primary metabolic process | 100.0% (2/2) | 2.69 | 0.024112 | 0.026391 |
| GO:0009058 | biosynthetic process | 100.0% (2/2) | 2.67 | 0.024599 | 0.026865 |
| GO:0060255 | regulation of macromolecule metabolic process | 100.0% (2/2) | 2.66 | 0.024978 | 0.027218 |
| GO:0043207 | response to external biotic stimulus | 100.0% (2/2) | 2.64 | 0.025686 | 0.027929 |
| GO:0016043 | cellular component organization | 100.0% (2/2) | 2.61 | 0.026671 | 0.028749 |
| GO:1901700 | response to oxygen-containing compound | 100.0% (2/2) | 2.61 | 0.026671 | 0.028749 |
| GO:0031323 | regulation of cellular metabolic process | 100.0% (2/2) | 2.62 | 0.026604 | 0.028802 |
| GO:0009607 | response to biotic stimulus | 100.0% (2/2) | 2.62 | 0.026563 | 0.02882 |
| GO:1901360 | organic cyclic compound metabolic process | 100.0% (2/2) | 2.6 | 0.027268 | 0.029329 |
| GO:0048518 | positive regulation of biological process | 100.0% (2/2) | 2.53 | 0.029835 | 0.032021 |
| GO:0071840 | cellular component organization or biogenesis | 100.0% (2/2) | 2.52 | 0.030234 | 0.03238 |
| GO:0022414 | reproductive process | 100.0% (2/2) | 2.51 | 0.030977 | 0.033104 |
| GO:0032501 | multicellular organismal process | 100.0% (2/2) | 2.47 | 0.032398 | 0.034548 |
| GO:0010033 | response to organic substance | 100.0% (2/2) | 2.46 | 0.033055 | 0.035174 |
| GO:0009628 | response to abiotic stimulus | 100.0% (2/2) | 2.38 | 0.036714 | 0.038984 |
| GO:0019222 | regulation of metabolic process | 100.0% (2/2) | 2.38 | 0.036999 | 0.039203 |
| GO:0009605 | response to external stimulus | 100.0% (2/2) | 2.33 | 0.039704 | 0.04198 |
| GO:0048856 | anatomical structure development | 100.0% (2/2) | 2.33 | 0.039796 | 0.041988 |
| GO:1901564 | organonitrogen compound metabolic process | 100.0% (2/2) | 2.2 | 0.047428 | 0.049935 |